NKX2-1/TITF1/TTF-1-Induced ROR1 Is Required to Sustain EGFR Survival Signaling in Lung Adenocarcinoma-Reference-Cited by-同舟云学术

NKX2-1/TITF1/TTF-1-Induced ROR1 Is Required to Sustain EGFR Survival Signaling in Lung Adenocarcinoma

Published:2012-03 Issue:3 Volume:21 Page:348-361
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Yamaguchi Tomoya,Yanagisawa Kiyoshi,Sugiyama Ryoji,Hosono Yasuyuki,Shimada Yukako,Arima Chinatsu,Kato Seiichi,Tomida Shuta,Suzuki Motoshi,Osada Hirotaka,Takahashi Takashi

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference47 articles.

1. Src kinase activation by direct interaction with the integrin beta cytoplasmic domain;Arias-Salgado;Proc. Natl. Acad. Sci. USA,2003

2. Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia;Baskar;Clin. Cancer Res.,2008

3. MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib;Bean;Proc. Natl. Acad. Sci. USA,2007

4. Akt activation by growth factors is a multiple-step process: the role of the PH domain;Bellacosa;Oncogene,1998

5. Thyroid transcription factor-1 (TTF-1/Nkx2.1/TITF1) gene regulation in the lung;Boggaram;Clin. Sci.,2009

Cited by 211 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel humanized monoclonal antibodies against ROR1 for cancer therapy;Molecular Cancer;2024-08-13

2. Polyoxygenated cembrane-type diterpenes from the Hainan soft coral Lobophytum crassum as a promising source of anticancer agents with ErbB3 and ROR1 inhibitory potential;Acta Pharmacologica Sinica;2024-07-29

3. Variant Transcript of ROR1 ENST00000545203 Does Not Encode ROR1 Protein;Biomedicines;2024-07-16

4. MicroRNA-532 as a probable diagnostic and therapeutic marker in cancer patients;Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis;2024-07

5. Discovery of Novel Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) Inhibitors for Cancer Treatment;Journal of Medicinal Chemistry;2024-06-24